Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1049
Peer-review started: November 26, 2022
First decision: December 26, 2022
Revised: January 6, 2023
Accepted: January 19, 2023
Article in press: January 19, 2023
Published online: February 16, 2023
Processing time: 79 Days and 23.2 Hours
Hepatic colon carcinoma invading the duodenum is not common in clinical pra
To discuss the efficacy and safety of duodenum-jejunum Roux-en-Y anastomosis for the treatment of hepatic colon carcinoma invading the duodenum.
From 2016 to 2020, 11 patients from Panzhihua Central Hospital diagnosed with hepatic colon carcinoma were enrolled in this study. Clinical and therapeutic effects and prognostic indicators were retrospectively analyzed to determine the efficacy and safety of our surgical procedures. All patients underwent radical resection of right colon cancer combined with duodenum-jejunum Roux-en-Y anastomosis.
The median tumor size was 65 mm (r50-90). Major complications (Clavien-DindoI-II) occurred in 3 patients (27.3%); the average length of hospital stay was 18.09 ± 4.21 d; and only 1 patient (9.1%) was readmitted during the 1st mo after the surgery. The 30-d mortality rate was 0%. After a median follow-up of 41 m (r7-58), the disease-free survival at 1, 2, and 3 years was 90.9%, 90.9% and 75.8%, respectively; the overall survival at 1, 2, and 3 years was 90.9%.
In selected patients, radical resection of right colon cancer combined with duodenum-jejunum Roux-en-Y anastomosis is clinically effective, and the complications are manageable. The surgical procedure also has an acceptable morbidity rate and mid-term survival.
Core Tip: In summary, radical right hemicolectomy and duodenum-jejunum Roux-en-Y anastomosis are feasible and safe in selected patients with colorectal carcinoma complicated with duodenal invasion, with a low incidence of postoperative complications and a good prognosis for tumor treatment. We still need larger prospective studies with longer follow-up to confirm these preliminary findings.